Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Original Research

Published on 11 Nov 2022

Association between remnant cholesterol and arterial stiffness in a Chinese community-based population: A cross-sectional study

in Lipids in Cardiovascular Disease

Jiahui Liu
Fangfang Fan
Bo Liu
Kaiyin Li
Yimeng Jiang
Jia Jia
Chuyun Chen
Bo Zheng
Yan Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.993097

2,771 views
22 citations

Original Research

Published on 08 Nov 2022

Analysis of blood lipid changes and influencing factors in physical examination population of a city in central China

in Lipids in Cardiovascular Disease

Boya Zhu
Wenjing Wang
Mengying Li
Shuzhen Peng
Xiaodong Tan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.996148

2,012 views

Case Report

Published on 07 Nov 2022

PCSK9 inhibitors in a renal transplant patient complicated with hepatitis B: A case report and literature review

in Lipids in Cardiovascular Disease

Pinchao Lv
Yuxi Li
Lin Wu
Haoyu Weng
Ming Chen
Wenhui Ding
Jianping Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.937474

3,251 views
3 citations

Systematic Review

Published on 03 Nov 2022

Associations of lipid profiles with the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis of prospective cohort studies

in Lipids in Cardiovascular Disease

Xiaoxian Gong
Luowei Chen
Bo Song
Xiang Han
Weihai Xu
Bo Wu
Feng Sheng
Min Lou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.893248

4,053 views
12 citations

Review

Published on 28 Oct 2022

Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome

in Lipids in Cardiovascular Disease

Gianni Biolo
Pierandrea Vinci
Alessandro Mangogna
Matteo Landolfo
Paolo Schincariol
Nicola Fiotti
Filippo Mearelli
Filippo Giorgio Di Girolamo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1028355

22,418 views
42 citations

Review

Published on 17 Oct 2022

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment

in Lipids in Cardiovascular Disease

Kexin Wang
Rui Wang
Jiaxin Yang
Xiaoli Liu
Hua Shen
Yan Sun
Yujie Zhou
Zhe Fang
Hailong Ge

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.913869

8,681 views
27 citations

Original Research

Published on 17 Oct 2022

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents

in Lipids in Cardiovascular Disease

Shuai Wang
Di Fu
Huixing Liu
Daoquan Peng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.934914

2,558 views
9 citations

Original Research

Published on 12 Oct 2022

Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity

in Lipids in Cardiovascular Disease

Michele Mietus-Snyder
William Suslovic
Meghan Delaney
Martin P. Playford
Rami A. Ballout
John R. Barber
James D. Otvos
Roberta L. DeBiasi
Nehal N. Mehta
Alan T. Remaley

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1033660

2,970 views
11 citations

Case Report

Published on 12 Oct 2022

Chylomicronemia through a burr hole: A case report

in Lipids in Cardiovascular Disease

Wann Jia Loh
Ramesh Bakthavachalam
Tavintharan Subramaniam
Sharon Pek
Fionn Chua
Lester Lee
Gerald F. Watts

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1020397

2,067 views
2 citations

Original Research

Published on 06 Oct 2022

Comparison between distinct insulin resistance indices in measuring the development of hypertension: The China Health and Nutrition Survey

in Lipids in Cardiovascular Disease

Yue Yuan
Wei Sun
Xiangqing Kong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.912197

3,283 views
19 citations

Review

Published on 04 Oct 2022

Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights

in Lipids in Cardiovascular Disease

Hsiang-Chun Lee
Alexander Akhmedov
Chu-Huang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.993633

10,244 views
22 citations

Systematic Review

Published on 30 Sep 2022

Red meat consumption and risk for dyslipidaemia and inflammation: A systematic review and meta-analysis

in Lipids in Cardiovascular Disease

Le Sun
Jia-Lin Yuan
Qiu-Cen Chen
Wen-Kang Xiao
Gui-Ping Ma
Jia-Hua Liang
Xiao-Kun Chen
Song Wang
Xiao-Xiong Zhou
Hui Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.996467

26,824 views
20 citations

Original Research

Published on 20 Sep 2022

Remnant cholesterol is associated with cardiovascular mortality

in Lipids in Cardiovascular Disease

Kerui Zhang
Xiangyun Qi
Fuyu Zhu
Quanbin Dong
Zhongshan Gou
Fang Wang
Li Xiao
Menghuan Li
Lianmin Chen
Yifeng Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.984711

7,498 views
22 citations

Perspective

Published on 15 Sep 2022

The rationale for the treatment of long-Covid symptoms – A cardiologist's view

in Lipids in Cardiovascular Disease

Elisabeth Schieffer
Bernhard Schieffer

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.992686

38,317 views
7 citations

Brief Research Report

Published on 13 Sep 2022

Increased atherosclerotic plaque in AOC3 knock-out in ApoE−/− mice and characterization of AOC3 in atherosclerotic human coronary arteries

in Lipids in Cardiovascular Disease

Anna Filip
Soraya Taleb
Rümeyza Bascetin
Mohammad Jahangiri
Matthieu Bardin
Cindy Lerognon
Bruno Fève
Patrick Lacolley
Sirpa Jalkanen
Nathalie Mercier

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.848680

3,612 views
4 citations

Review

Published on 08 Sep 2022

Targets of statins intervention in LDL-C metabolism: Gut microbiota

in Lipids in Cardiovascular Disease

ChangXin Sun
ZePing Wang
LanQing Hu
XiaoNan Zhang
JiYe Chen
ZongLiang Yu
LongTao Liu
Min Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.972603

9,104 views
15 citations